207 related articles for article (PubMed ID: 33448076)
1. The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours.
Wruck W; Bremmer F; Kotthoff M; Fichtner A; Skowron MA; Schönberger S; Calaminus G; Vokuhl C; Pfister D; Heidenreich A; Albers P; Adjaye J; Nettersheim D
J Cell Mol Med; 2021 Feb; 25(3):1394-1405. PubMed ID: 33448076
[TBL] [Abstract][Full Text] [Related]
2. Analysis of GATA3 and FOXA2 expression suggests that downregulation of genes involved in the maintenance of a mature yolk sac tumor phenotype may underlie sarcomatoid transformation.
Ricci C; Ambrosi F; Grillini A; Massari F; Fiorentino M; Colecchia M; Ulbright TM; Acosta AM
Virchows Arch; 2024 Apr; 484(4):709-713. PubMed ID: 38141134
[TBL] [Abstract][Full Text] [Related]
3. Involvement of adenomatous polyposis coli (APC) gene in testicular yolk sac tumor of infants.
Kato N; Shibuya H; Fukase M; Tamura G; Motoyama T
Hum Pathol; 2006 Jan; 37(1):48-53. PubMed ID: 16360415
[TBL] [Abstract][Full Text] [Related]
4. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.
Ramalingam P; Malpica A; Silva EG; Gershenson DM; Liu JL; Deavers MT
Am J Surg Pathol; 2004 Nov; 28(11):1499-505. PubMed ID: 15489654
[TBL] [Abstract][Full Text] [Related]
5. Yolk sac tumours revisited. A review of their many faces and names.
Nogales FF; Preda O; Nicolae A
Histopathology; 2012 Jun; 60(7):1023-33. PubMed ID: 22008025
[TBL] [Abstract][Full Text] [Related]
6. FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type.
Ricci C; Ambrosi F; Franceschini T; Giunchi F; Di Filippo G; Franchini E; Massari F; Mollica V; Tateo V; Bianchi FM; Colecchia M; Acosta AM; Fiorentino M
Histopathology; 2023 Sep; 83(3):465-476. PubMed ID: 37317674
[TBL] [Abstract][Full Text] [Related]
7. Expression pattern of clinically relevant markers in paediatric germ cell- and sex-cord stromal tumours is similar to adult testicular tumours.
Mosbech CH; Svingen T; Nielsen JE; Toft BG; Rechnitzer C; Petersen BL; Rajpert-De Meyts E; Hoei-Hansen CE
Virchows Arch; 2014 Nov; 465(5):567-77. PubMed ID: 25074678
[TBL] [Abstract][Full Text] [Related]
8. ZBTB16 is a sensitive and specific marker in detection of metastatic and extragonadal yolk sac tumour.
Xiao GQ; Priemer DS; Wei C; Aron M; Yang Q; Idrees MT
Histopathology; 2017 Oct; 71(4):562-569. PubMed ID: 28581124
[TBL] [Abstract][Full Text] [Related]
9. RNA-binding protein LIN28 is a sensitive marker of pediatric yolk sac tumors.
Feng S; Huang S; Tong Y; Chen Z; Shen D; Wu D; Lai XH; Chen X
Pediatr Surg Int; 2016 Aug; 32(8):819-25. PubMed ID: 27357399
[TBL] [Abstract][Full Text] [Related]
10. A diagnostic immunohistochemical panel for yolk sac (primitive endodermal) tumours based on an immunohistochemical comparison with the human yolk sac.
Nogales FF; Quiñonez E; López-Marín L; Dulcey I; Preda O
Histopathology; 2014 Jul; 65(1):51-9. PubMed ID: 24444105
[TBL] [Abstract][Full Text] [Related]
11. The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression.
Murray MJ; Saini HK; van Dongen S; Palmer RD; Muralidhar B; Pett MR; Piipari M; Thornton CM; Nicholson JC; Enright AJ; Coleman N
Mol Cancer; 2010 Nov; 9():290. PubMed ID: 21059207
[TBL] [Abstract][Full Text] [Related]
12. Role of HNF1β in the differential diagnosis of yolk sac tumor from other germ cell tumors.
Rougemont AL; Tille JC
Hum Pathol; 2018 Nov; 81():26-36. PubMed ID: 29753846
[TBL] [Abstract][Full Text] [Related]
13. Yolk sac tumours of the female genital tract in older adults derive commonly from somatic epithelial neoplasms: somatically derived yolk sac tumours.
McNamee T; Damato S; McCluggage WG
Histopathology; 2016 Nov; 69(5):739-751. PubMed ID: 27334714
[TBL] [Abstract][Full Text] [Related]
14. SALL4 is a useful marker for pediatric yolk sac tumors.
Wu P; Luo R; Sun B; Zhao J; Xu Q; Feng S; Chen X; Wang C
Pediatr Surg Int; 2020 Jun; 36(6):727-734. PubMed ID: 32222813
[TBL] [Abstract][Full Text] [Related]
15. Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance.
Jeyapalan JN; Noor DA; Lee SH; Tan CL; Appleby VA; Kilday JP; Palmer RD; Schwalbe EC; Clifford SC; Walker DA; Murray MJ; Coleman N; Nicholson JC; Scotting PJ
Br J Cancer; 2011 Aug; 105(4):575-85. PubMed ID: 21712824
[TBL] [Abstract][Full Text] [Related]
16. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
Cao D; Guo S; Allan RW; Molberg KH; Peng Y
Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor GATA-4 is expressed in pediatric yolk sac tumors.
Siltanen S; Anttonen M; Heikkilä P; Narita N; Laitinen M; Ritvos O; Wilson DB; Heikinheimo M
Am J Pathol; 1999 Dec; 155(6):1823-9. PubMed ID: 10595911
[TBL] [Abstract][Full Text] [Related]
18. Updating germ cell tumour pathogenesis - the ability of seminomas for FOXA2-driven extra-embryonic differentiation.
Bremmer F; Lubk L; Ströbel P; Nettersheim D
Histopathology; 2023 Sep; 83(3):477-481. PubMed ID: 37265221
[TBL] [Abstract][Full Text] [Related]
19. Primary germ cell tumors of the mediastinum: III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum--a clinicopathologic and immunohistochemical study of 64 cases.
Moran CA; Suster S; Koss MN
Cancer; 1997 Aug; 80(4):699-707. PubMed ID: 9264353
[TBL] [Abstract][Full Text] [Related]
20. Interphase cytogenetics on paraffin sections of paediatric extragonadal yolk sac tumours.
Jenderny J; Köster E; Borchers O; Meyer A; Grote W; Harms D; Jänig U
Virchows Arch; 1996 Apr; 428(1):53-7. PubMed ID: 8646370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
